The Food and Drug Administration has approved Piqray (alpelisib) tablets to treat men and postmenopausal women whose advanced breast cancer is hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative and PIK3CA-mutated.
Piqray is to be used in combination with the FDA-approved endocrine therapy fulvestrant. The PIK3CA-mutated, advanced or metastatic breast cancer (as detected by an FDA-approved test) is indicated following progression on or after an endocrine-based regimen.
Continue reading “FDA approves new drug to treat advanced breast cancer”
At UW Medical Center pre-op center with the awesome heated air blanket! This is what is on tap for me later today if all goes well.
“In the first procedure, called lymphovenous bypass, surgeons peer through a microscope and use minute instruments to connect blocked lymphatic vessels as small as 0.3 millimeters in diameter to a nearby vein. The bypass allows excess lymph fluid to flow more freely.
“In the second procedure, called lymph node transfer, surgeons microsurgically transplant healthy lymph nodes that have a rich blood supply to an area of lymphatic injury to re-establish lymphatic connections.”
Continue reading “Cancer, the gift that keeps on giving: LVA and LNT on deck”